NL9100434A - Farmaceutische preparaten voor de bestrijding van virale infecties en immuundeficientieziekten, de bereiding en toepassing daarvan. - Google Patents

Farmaceutische preparaten voor de bestrijding van virale infecties en immuundeficientieziekten, de bereiding en toepassing daarvan. Download PDF

Info

Publication number
NL9100434A
NL9100434A NL9100434A NL9100434A NL9100434A NL 9100434 A NL9100434 A NL 9100434A NL 9100434 A NL9100434 A NL 9100434A NL 9100434 A NL9100434 A NL 9100434A NL 9100434 A NL9100434 A NL 9100434A
Authority
NL
Netherlands
Prior art keywords
cells
polypeptides
aids
functional groups
amino acids
Prior art date
Application number
NL9100434A
Other languages
English (en)
Dutch (nl)
Original Assignee
Rijksuniversiteit
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rijksuniversiteit filed Critical Rijksuniversiteit
Priority to NL9100434A priority Critical patent/NL9100434A/nl
Priority to EP92906661A priority patent/EP0575432B1/en
Priority to DE69233455T priority patent/DE69233455T2/de
Priority to JP4506421A priority patent/JP2690813B2/ja
Priority to DK92906661T priority patent/DK0575432T3/da
Priority to AT92906661T priority patent/ATE284222T1/de
Priority to AU15663/92A priority patent/AU1566392A/en
Priority to ES92906661T priority patent/ES2233923T3/es
Priority to PCT/NL1992/000036 priority patent/WO1992015316A1/en
Publication of NL9100434A publication Critical patent/NL9100434A/nl
Priority to US08/923,232 priority patent/US5869457A/en
Priority to HK98111473A priority patent/HK1010684A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/38—Albumins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
    • C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • AIDS & HIV (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL9100434A 1991-03-11 1991-03-11 Farmaceutische preparaten voor de bestrijding van virale infecties en immuundeficientieziekten, de bereiding en toepassing daarvan. NL9100434A (nl)

Priority Applications (11)

Application Number Priority Date Filing Date Title
NL9100434A NL9100434A (nl) 1991-03-11 1991-03-11 Farmaceutische preparaten voor de bestrijding van virale infecties en immuundeficientieziekten, de bereiding en toepassing daarvan.
AT92906661T ATE284222T1 (de) 1991-03-11 1992-02-24 Modifizierte proteine und deren verwendung zur kontrolle von virusinfektionen
DE69233455T DE69233455T2 (de) 1991-03-11 1992-02-24 Modifizierte proteine und deren verwendung zur kontrolle von virusinfektionen
JP4506421A JP2690813B2 (ja) 1991-03-11 1992-02-24 修飾タンパク質およびそれを用いたウイルス感染症を制御するための医薬製剤
DK92906661T DK0575432T3 (en) 1991-03-11 1992-02-24 Modified proteins and their use for controlling viral infections.
EP92906661A EP0575432B1 (en) 1991-03-11 1992-02-24 Modified proteins and their use for controlling viral infections
AU15663/92A AU1566392A (en) 1991-03-11 1992-02-24 Modified proteins and their use for controlling viral infections
ES92906661T ES2233923T3 (es) 1991-03-11 1992-02-24 Proteinas modificadas y su uso para controlar infecciones viricas.
PCT/NL1992/000036 WO1992015316A1 (en) 1991-03-11 1992-02-24 Modified proteins and their use for controlling viral infections
US08/923,232 US5869457A (en) 1991-03-11 1997-09-04 Modified proteins and their use for controlling viral infections
HK98111473A HK1010684A1 (en) 1991-03-11 1998-10-22 Modified proteins and their use for controlling viral infections.

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL9100434A NL9100434A (nl) 1991-03-11 1991-03-11 Farmaceutische preparaten voor de bestrijding van virale infecties en immuundeficientieziekten, de bereiding en toepassing daarvan.
NL9100434 1991-03-11

Publications (1)

Publication Number Publication Date
NL9100434A true NL9100434A (nl) 1992-10-01

Family

ID=19859005

Family Applications (1)

Application Number Title Priority Date Filing Date
NL9100434A NL9100434A (nl) 1991-03-11 1991-03-11 Farmaceutische preparaten voor de bestrijding van virale infecties en immuundeficientieziekten, de bereiding en toepassing daarvan.

Country Status (10)

Country Link
EP (1) EP0575432B1 (es)
JP (1) JP2690813B2 (es)
AT (1) ATE284222T1 (es)
AU (1) AU1566392A (es)
DE (1) DE69233455T2 (es)
DK (1) DK0575432T3 (es)
ES (1) ES2233923T3 (es)
HK (1) HK1010684A1 (es)
NL (1) NL9100434A (es)
WO (1) WO1992015316A1 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993010799A1 (en) * 1991-11-27 1993-06-10 Immtech International Incorporated Method of treating viral infections
US5405832A (en) * 1991-11-27 1995-04-11 Immtech International Inc. Method of treating non-streptococcal bacterial infections
AU4835693A (en) * 1993-08-13 1995-03-14 Rijksuniversiteit Te Groningen Pharmaceutical composition comprising phosphatase or a derivative thereof
AUPM623994A0 (en) * 1994-06-15 1994-07-07 Biomolecular Research Institute Limited Antiviral dendrimers
US5985275A (en) * 1995-04-12 1999-11-16 New York Blood Center β-Lactoglobulin modified with aromatic anhydride compound for preventing HIV infection
WO1997034619A1 (en) * 1996-03-20 1997-09-25 New York Blood Center Methods of treating herpes or chlamydia
US5952009A (en) * 1996-03-20 1999-09-14 New York Blood Center Methods for preventing the transmission of or treating patients infected with herpesvirus
EP1426382A1 (en) * 2002-12-06 2004-06-09 Aventis Behring GmbH Antiviral human serum albumin
EP1625851A4 (en) 2003-05-16 2007-12-26 Bbk Bio Corp PREPARATION FOR PREVENTING CONTACT OF PATHOGEN BROOMS WITH A LIVING ORGANISM
FR2862134B1 (fr) * 2003-11-12 2007-07-27 Sebia Sa Analyse et typage de proteines monoclonales par electrophorese capillaire et immunodeplacement
CN109675042B (zh) * 2019-02-01 2021-03-23 山西锦波生物医药股份有限公司 用于治疗和/或预防流感的组合物、方法和用途
RU2716003C1 (ru) * 2019-09-09 2020-03-05 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт вакцин и сывороток им. И.И. Мечникова" (ФГБНУ НИИВС им. И.И. Мечникова) Применение сывороточного альбумина в качестве противомикробного агента

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990007340A1 (en) * 1989-01-09 1990-07-12 Meiji Milk Products Co., Ltd. Anti-hiv agent

Also Published As

Publication number Publication date
HK1010684A1 (en) 1999-06-25
ATE284222T1 (de) 2004-12-15
DE69233455T2 (de) 2005-12-22
JP2690813B2 (ja) 1997-12-17
ES2233923T3 (es) 2005-06-16
EP0575432A1 (en) 1993-12-29
DE69233455D1 (de) 2005-01-13
WO1992015316A1 (en) 1992-09-17
EP0575432B1 (en) 2004-12-08
JPH06505264A (ja) 1994-06-16
DK0575432T3 (en) 2005-04-04
AU1566392A (en) 1992-10-06

Similar Documents

Publication Publication Date Title
Balzarini et al. The mannose-specific plant lectins from Cymbidium hybrid and Epipactis helleborine and the (N-acetylglucosamine) n-specific plant lectin from Urtica dioica are potent and selective inhibitors of human immunodeficiency virus and cytomegalovirus replication in vitro
JP4482054B2 (ja) 細胞内の物質移送のための抗体から誘導されたベクター
Balzarini et al. Alpha-(1-3)-and alpha-(1-6)-D-mannose-specific plant lectins are markedly inhibitory to human immunodeficiency virus and cytomegalovirus infections in vitro
Jansen et al. Potent in vitro anti-human immunodeficiency virus-1 activity of modified human serum albumins.
NL9100434A (nl) Farmaceutische preparaten voor de bestrijding van virale infecties en immuundeficientieziekten, de bereiding en toepassing daarvan.
Lozano et al. Targeting HIV entry through interaction with envelope glycoprotein 120 (gp120): synthesis and antiviral evaluation of 1, 3, 5-triazines with aromatic amino acids
Clayton et al. Evaluation of the synthesis of sialic acid-PAMAM glycodendrimers without the use of sugar protecting groups, and the anti-HIV-1 properties of these compounds
JP2002511753A (ja) Ｔｘｕ−７−ｐａｐ イムノトキシン及びその使用
US5869457A (en) Modified proteins and their use for controlling viral infections
Martínez-Gualda et al. Structure-activity relationship studies on a Trp dendrimer with dual activities against HIV and enterovirus A71. Modifications on the amino acid
Bui et al. Virus-free method to control and enhance extracellular vesicle cargo loading and delivery
JP2000505076A (ja) エイズ治療用免疫複合体
DE60221805T2 (de) Peptide mit affinität zu gp120, und ihre verwendungen
WO2004011595A2 (fr) Vecteurs destines au transfert de molecules d'interet dans des cellules cibles
KR0128098B1 (ko) 항hiv제
JP3109678B2 (ja) アメリカやまごぼう抗ウイルス蛋白質―モノクローナル抗体コンジュゲート
JP2867279B2 (ja) 毒素で修飾された抗体
JP5004408B2 (ja) 抗ｈｉｖ組成物、その製造方法及び医薬
KR100468899B1 (ko) 당사슬인식항체를함유하는hiv감염증치료제
FR3064486A1 (fr) Prevention d'une infection par le virus respiratoire syncytial dans les voies respiratoires superieures
Owada et al. Anti‐HIV‐1 Activity of an lonically Modified Porous Polypropylene Membrane Determined by Filtration of a Viral Suspension
JP2696379B2 (ja) 抗ｈｉｖ剤
JPH01165525A (ja) レトロウイルス感染症治療および予防用薬剤
WO2004052931A1 (en) Negatively charged antiviral protein conjugates
Gilljam Use of Lectins in Affinity Purification of HIV and SIV Envelope Glycoproteins

Legal Events

Date Code Title Description
A1B A search report has been drawn up
BV The patent application has lapsed